GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » DeferredTaxAndRevenue

Labiana Health (XMAD:LAB) DeferredTaxAndRevenue : €0.00 Mil (As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Labiana Health's current deferred tax and revenue for the quarter that ended in Dec. 2022 was €0.00 Mil.

Labiana Health DeferredTaxAndRevenue Historical Data

The historical data trend for Labiana Health's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health DeferredTaxAndRevenue Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
DeferredTaxAndRevenue
- - -

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
DeferredTaxAndRevenue - - - -

Labiana Health DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Labiana Health's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.